Clinical Trials Browser

INDUSTRY × Has results × reparixin × Clear all

NCT02370238 2022-09-16

FRIDA

Phase 2 Completed

194 enrolled 19 charts

Breast Neoplasms

NCT01861054 2021-05-14

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Phase 2 Terminated

20 enrolled 16 charts

Breast Neoplasms